Asia Pacific Fish Vaccines Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Fish Vaccines Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Fish Vaccines Market – Key Market Dynamics

5.1 Growth Drivers

5.2 Market Opportunities

5.3 Future Trends

5.4 Impact of Drivers and Restraints

6. Asia Pacific Fish Vaccines Market Regional Analysis

6.1 Asia Pacific Fish Vaccines Market Overview

6.2 Asia Pacific Fish Vaccines Market Revenue 2020-2030 (US$ Million)

6.3 Asia Pacific Fish Vaccines Market Forecast Analysis

7. Asia Pacific Fish Vaccines Market Analysis – by Vaccine Type

7.1 Inactivated Vaccines

7.1.1 Overview
7.1.2 Inactivated Vaccines: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Live Attenuated Vaccines

7.2.1 Overview
7.2.2 Live Attenuated Vaccines: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Subunit Vaccines

7.3.1 Overview
7.3.2 Subunit Vaccines: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Recombinant Vector Vaccine

7.4.1 Overview
7.4.2 Recombinant Vector Vaccine: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Fish Vaccines Market Analysis – by Application

8.1 Bacterial Infection

8.1.1 Overview
8.1.2 Bacterial Infection: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Viral Infection

8.2.1 Overview
8.2.2 Viral Infection: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Parasitic

8.3.1 Overview
8.3.2 Parasitic: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Fish Vaccines Market Analysis – by Route of Administration

9.1 Injection Vaccine

9.1.1 Overview
9.1.2 Parasitic: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Immersion Vaccine

9.2.1 Overview
9.2.2 Parasitic: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Oral Vaccine

9.3.1 Overview
9.3.2 Parasitic: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Fish Vaccines Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia Pacific Fish Vaccines Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Asia Pacific Fish Vaccines Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 China: Asia Pacific Fish Vaccines Market Breakdown, by Vaccine Type
10.1.1.1.2 China: Asia Pacific Fish Vaccines Market Breakdown, by Application
10.1.1.1.3 China: Asia Pacific Fish Vaccines Market Breakdown, by Route of Administration

10.1.1.2 India: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 India: Asia Pacific Fish Vaccines Market Breakdown, by Vaccine Type
10.1.1.2.2 India: Asia Pacific Fish Vaccines Market Breakdown, by Application
10.1.1.2.3 India: Asia Pacific Fish Vaccines Market Breakdown, by Route of Administration

10.1.1.3 Japan: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Japan: Asia Pacific Fish Vaccines Market Breakdown, by Vaccine Type
10.1.1.3.2 Japan: Asia Pacific Fish Vaccines Market Breakdown, by Application
10.1.1.3.3 Japan: Asia Pacific Fish Vaccines Market Breakdown, by Route of Administration

10.1.1.4 Australia: Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Australia: Asia Pacific Fish Vaccines Market Breakdown, by Vaccine Type
10.1.1.4.2 Australia: Asia Pacific Fish Vaccines Market Breakdown, by Application
10.1.1.4.3 Australia: Asia Pacific Fish Vaccines Market Breakdown, by Route of Administration

10.1.1.5 Rest of Asia-Pacific : Asia Pacific Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Fish Vaccines Market Breakdown, by Vaccine Type
10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Fish Vaccines Market Breakdown, by Application
10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Fish Vaccines Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia Pacific Fish Vaccines Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Choong Ang Vaccine Laboratories Co.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Elanco Animal Health Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Hipra SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 INDIAN IMMUNOLOGICALS LTD

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 KBNP Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Kyoto Biken Laboratories

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Merck & Co Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Nisseiken Co., Ltd.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Phibro Animal Health Corp

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Vaxxinova International BV

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Zoetis Inc.

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights